Join participants from across the country – pancreatic cancer survivors, caregivers and volunteers – as we advocate for increased funding for pancreatic cancer research. It's time to tell Congress that together, we can make the impossible possible for patients everywhere!
UNC Lineberger researchers driven to fight pancreatic cancer
Kirsten Bryant, PhD, a cancer researcher and postdoctoral fellow at the UNC Lineberger Comprehensive Cancer Center, and Channing Der, PhD, a UNC Lineberger member and the Sarah Graham Kenan Professor of Pharmacology, shared personal stories of why they're driven to fight pancreatic cancer at a breakfast in Durham on Tuesday. See the full article here: https://unclineberger.org/news/unc-lineberger-researchers-driven-to-fight-pancreatic-cancer?utm_source=lineup&utm_medium=email&utm_campaign=10
Purple is the New Black
Dr. Channing Der and the rest of the lab were featured in an article on the Carolina Scientific blog. The article highlights the science the lab is developing as well as the motivation behind the work for many members of the lab. To see the full article visit the Carolina Scientific website here: http://www.carolinascientific.org/blog/2016/3/6/karriuinq0hkifsfj50nznalaiqxup The Carolina … Continue reading Purple is the New Black
Meagan Ryan Awarded AACR-Woman in Cancer Research Scholar Award
Meagan Ryan, graduate student in the Der and Cox Labs and CCBTP trainee, has been selected to receive a Women in Cancer Research (WICR) Scholar Award. These awards are given annually to WICR members who are scientists-in-training and presenters of meritorious scientific papers at the AACR Annual Meeting. Meagan will present her poster on "Inhibition … Continue reading Meagan Ryan Awarded AACR-Woman in Cancer Research Scholar Award
Channing Der Serves as Thesis Opponent
Dr. Channing Der served as a thesis opponent to Arafath Kaja Najumudeen today at the Abo Akademi University in Turku, Finland. Arafath completed his PhD studies on the Ras oncogene.
Promising direction for the treatment of pancreatic cancers driven by KRAS mutation
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found a promising strategy that may limit the growth of pancreatic cancers in patients with a mutation in a gene called KRAS. More than 95 percent of pancreatic cancers have KRAS mutations, and there's strong evidence that blocking the gene's function could be a very … Continue reading Promising direction for the treatment of pancreatic cancers driven by KRAS mutation
Kirsten Bryant awarded Pathway to Leadership Grant
GRANTEE: KIRSTEN BRYANT, PHD University of North Carolina at Chapel Hill Research Project: Exploiting pancreatic cancer cell metabolism for therapeutic gain Award: 2015 Pancreatic Cancer Action Network – AACR Pathway to Leadership Grant Award Period: October 1, 2015 – September 30, 2020 Amount: $600,000 Biographical Highlights Dr. Bryant is currently a postdoctoral researcher in the laboratory … Continue reading Kirsten Bryant awarded Pathway to Leadership Grant
Cox and Der lead team to $2M+ NCI U01 grant
A research team led by Drs. Adrienne D. Cox and Channing J. Der (members of the UNC Lineberger Program in Molecular Therapeutics) is one of the first recipients of an NCI U01 grant on New Approaches to Synthetic Lethality for Mutant KRas-Dependent Cancers. Their team, which also includes Drs. Ben Major at UNC, Kris Wood … Continue reading Cox and Der lead team to $2M+ NCI U01 grant
New Grants awarded in the Der Lab
Channing Der awarded NCI grant to pursue drug discovery Channing J. Der, PhD, UNC Lineberger member and Kenan Distinguished Professor in the Department of Pharmacology at the UNC School of Medicine, was awarded a five-year NIH R01 grant entitled "Biological Activity of RAS Oncogenes". This grant will support his studies to pursue drug discovery for … Continue reading New Grants awarded in the Der Lab
Leanna Gentry defends phd thesis
On September 3rd Leanna Gentry, from the Department of Pharmacology, defended her thesis entitled “Targeting the Ras-Ral effector pathway for cancer treatment." Leanna is the 23rd graduating member of the Der Lab, and will continue her scientific pursuits as she begins work at CATO Research. After the defense the Lab members treated Leanna to a fabulous … Continue reading Leanna Gentry defends phd thesis
Der Lab 